CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD) IN SEPTIC PATIENTS

被引：0
|
作者：
MANNS, M [1 ]
SIGLER, MH [1 ]
TEEHAN, BP [1 ]
机构：
[1] LANKENAU HOSP,MED RES CTR,WYNNEWOOD,PA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1995年 / 6卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：497 / 497
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS AND DOSAGE RECOMMENDATIONS OF TEICOPLANIN IN PATIENTS TREATED BY CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD)
    WOLTER, K
    CLAUS, M
    FRITSCHKA, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 46 (02) : 179 - 180
  • [2] Clearance of levofloxacin by an in vitro model of continuous venovenous hemodialysis (CVVHD)
    Siewert, S.
    Drewelow, B.
    Mueller, S. C.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (10): : 889 - 895
  • [3] ELIMINATION OF FLUCONAZOLE DURING CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD) IN A SINGLE PATIENT
    WOLTER, K
    MARGGRAF, G
    DERMOUMI, H
    FRITSCHKA, E
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 47 (03) : 291 - 292
  • [4] ADVANTAGES OF CONTINUOUS VENOVENOUS HEMODIALYSIS (CVVHD) IN ACUTE-RENAL-FAILURE
    MANNS, M
    SIGLER, MH
    TEEHAN, BP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 470 - 470
  • [5] Clearance of ceftazidime (TAZ) by continuous venovenous hemofiltration (CVVH) and hemodialysis (CVVHD).
    Matzke, GR
    Joy, MS
    Frye, RF
    Palevsky, P
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1360 - A1360
  • [6] A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD)
    Mitchell, A
    Daul, AE
    Beiderlinden, M
    Schäfers, RF
    Heemann, U
    Kribben, A
    Peters, J
    Philipp, T
    Wenzel, RR
    CLINICAL NEPHROLOGY, 2003, 59 (02) : 106 - 114
  • [7] Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
    Wilson, F. Perry
    Berns, Jeffrey S.
    CLINICAL NEPHROLOGY, 2012, 77 (04) : 329 - 331
  • [8] A retrospective study of outcomes in pediatric hematology/oncology patients receiving continuous venovenous hemodialysis (CVVHD)
    Avent, Y.
    Henderson, N.
    Collie, T.
    Tamburro, R. F.
    Elbahlawan, L.
    Morrison, R. R.
    Rajasekaran, S.
    PEDIATRIC NEPHROLOGY, 2008, 23 (10) : 1899 - 1900
  • [9] Time to clotting in citrate versus acetate dialysate in continuous venovenous hemodialysis (CVVHD).
    Lau, SM
    Barton, DP
    O'Brien, KR
    Wright, EJ
    Larive, B
    Paganini, EP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 731A - 731A
  • [10] Effect of Continuous Venovenous Hemodialysis ( CVVHD) on the Time to Reach Therapeutic Vancomycin Levels
    Quickfall, Danica
    Koyner, Jay L.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
12345